Hürthle cell hurdles: Why do tumors derived from this cell type refuse to reveal their secrets and weaknesses?
作者信息
Sadow Peter M
机构信息
Departments of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
出版信息
Cancer Cytopathol. 2021 May;129(5):335-336. doi: 10.1002/cncy.22377. Epub 2020 Oct 12.
Abstract
摘要
相似文献
1
Hürthle cell hurdles: Why do tumors derived from this cell type refuse to reveal their secrets and weaknesses?许特耳细胞的难题：为何源自这种细胞类型的肿瘤不愿暴露其奥秘与弱点？
Cancer Cytopathol. 2021 May;129(5):335-336. doi: 10.1002/cncy.22377. Epub 2020 Oct 12.
2
The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.甲状腺许特莱（嗜酸性）细胞及其相关病理状况：外科病理学与细胞病理学综述
Arch Pathol Lab Med. 2008 Aug;132(8):1241-50. doi: 10.5858/2008-132-1241-TTHOCA.
3
The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.在甲状腺细针抽吸物的大多数 Bethesda 类别中，Hurthle 细胞的存在并不会增加恶性肿瘤的风险。
Thyroid. 2020 Mar;30(3):425-431. doi: 10.1089/thy.2019.0190.
4
Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.低分化嗜酸性（许特莱细胞）滤泡癌：一项机构经验。
Endocr Pathol. 2015 May;26(2):164-9. doi: 10.1007/s12022-015-9367-6.
5
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?在甲状腺细针穿刺中，嗜酸性细胞病变/肿瘤比滤泡性病变/肿瘤更能预测恶性肿瘤吗？
Diagn Cytopathol. 2006 May;34(5):330-4. doi: 10.1002/dc.20440.
6
Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?甲状腺细针穿刺细胞学检查中的许特尔细胞：一个潜在的诊断难题？
Malays J Pathol. 2015 Apr;37(1):49-52.
7
Hurthle cell tumor of the thyroid gland in an infant.婴儿甲状腺的许特耳细胞肿瘤。
Arch Pathol (Chic). 1945 Nov-Dec;40:387-91.
8
The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.甲状腺结节性疾病细针穿刺细胞学检查中许特耳细胞的意义及预测价值
Eur J Surg Oncol. 2004 Sep;30(7):786-9. doi: 10.1016/j.ejso.2004.05.017.
9
Intrathoracic Hürthle cell (oxyphil cell) tumor of the thyroid.甲状腺胸内许特莱细胞（嗜酸性细胞）肿瘤
Am J Surg. 1953 Apr;85(4):534-8. doi: 10.1016/0002-9610(53)90541-8.
10
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario.甲状腺嗜酸细胞性肿瘤的细胞学诊断：临床情况的重要性
Appl Immunohistochem Mol Morphol. 2019 Nov/Dec;27(10):726-731. doi: 10.1097/PAI.0000000000000713.
本文引用的文献
1
Cytomorphologic features of NTRK-rearranged thyroid carcinoma.NTRK 重排型甲状腺癌的细胞形态特征。
Cancer Cytopathol. 2020 Nov;128(11):812-827. doi: 10.1002/cncy.22374. Epub 2020 Oct 19.
2
Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology-histology correlation.甲状腺 Hurthle 细胞肿瘤的分子改变：细针抽吸细胞学与细胞-组织学相关性研究。
Cancer Cytopathol. 2021 May;129(5):363-373. doi: 10.1002/cncy.22370. Epub 2020 Oct 12.
3
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.激酶融合相关甲状腺癌的临床病理特征：整合分析及分子特征描述。
Mod Pathol. 2020 Dec;33(12):2458-2472. doi: 10.1038/s41379-020-0638-5. Epub 2020 Jul 31.
4
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).NTRK 重排型甲状腺癌（NRTC）的临床病理和分子特征。
Mod Pathol. 2020 Nov;33(11):2186-2197. doi: 10.1038/s41379-020-0574-4. Epub 2020 May 26.
5
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.Hürthle 细胞癌的综合基因组分析揭示了致癌驱动因素、反复发生的线粒体突变和独特的染色体景观。
Cancer Cell. 2018 Aug 13;34(2):256-270.e5. doi: 10.1016/j.ccell.2018.07.002.
6
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.广泛的染色体缺失和线粒体 DNA 改变作为 Hurthle 细胞癌的遗传驱动因素。
Cancer Cell. 2018 Aug 13;34(2):242-255.e5. doi: 10.1016/j.ccell.2018.06.013.
Zotero 插件